Actively Recruiting
NIATx Implementation to Expand Opioid Agonist Therapy in Central Asia Improving Treatment Access and HIV Prevention in PWID Populations
Led by Yale University · Updated on 2026-10-14
900
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the expansion of opioid agonist therapies OAT in Central Asia to address the rapidly growing HIV epidemic, primarily affecting people who inject drugs PWID and their sexual partners. This health services research focuses on scaling up OAT in Kazakhstan, Kyrgyzstan, and Tajikistan using the Network for the Improvement of Addiction Treatment NIATx strategy guided by the Exploration-Planning-Implementation-Sustainment EPIS framework. The study aims to understand and improve OAT delivery in these countries with low coverage and multiple barriers. The intervention involves training and coaching national experts and Chief Narcologists from regions within the three countries through NIATx, which includes in-depth coaching, collaborative learning, and quality improvement tools. Participants will engage in formative research, organizational assessments, and focus groups to identify barriers and facilitators to OAT entry and retention. The approach is tailored to local contexts and aims to create sustainable OAT models integrated into primary and HIV clinical care. Participants will be involved in surveys, focus groups, and organizational assessments over a 36-month period, with data collected on OAT census, new patient enrollments, and dropout rates by region. The study includes ongoing stakeholder meetings to guide implementation and policy changes for sustainability. The primary outcomes focus on OAT scale-up and retention, with secondary outcomes tracking new patient numbers and dropout rates, aiming to build regional expertise and support long-term program success.
CONDITIONS
Brief Title
Expanding Medication-Assisted Therapies in Central Asia
Research Team
F
Frederick L Altice, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here